Haematological malignancies: at the forefront of immunotherapeutic innovation
Crossref DOI link: https://doi.org/10.1038/nrc3907
Published Online: 2015-03-19
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bachireddy, Pavan
Burkhardt, Ute E.
Rajasagi, Mohini
Wu, Catherine J.
Text and Data Mining valid from 2015-03-19
Version of Record valid from 2015-03-19
Article History
First Online: 19 March 2015
Competing interests
: Pavan Bachireddy is a consultant for Jounce Therapeutics.